SCHEMBL365210

SCHEMBL365210

CS(=O)(=O)NC(=O)c1ccc(COc2ccc(Cl)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
BCL2L1 Q07817 4/20 0.62
MCL1 Q07820 4/20 0.62
NR4A2 P43354 1/20 0.61
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
PKM P14618 1/20 0.57
SCN9A Q15858 2/20 0.57
MEN1 O00255 1/20 0.54
POLB P06746 1/20 0.54
KMT2A Q03164 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
ALDH1A1 P00352 3/20 0.53
MAPT P10636 3/20 0.53
HTT P42858 2/20 0.53
SCN5A Q14524 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL366081 1.00 MAOA (0.63) MAOAMAOBBCL2L1MCL1NR4A2
Diethylamine SCHEMBL16239880 0.94 MAOA (0.56) MAOAMAOBBCL2L1MCL1NR4A2
SCHEMBL367348 0.88 BCL2L1 (0.57) MAOAMAOBBCL2L1MCL1NR4A2
SCHEMBL365645 0.88 ALDH1A1 (0.70) BCL2L1MCL1NPC1RAB9ASCN9A
SCHEMBL16239768 0.88 ALDH1A1 (0.70) BCL2L1MCL1NPC1RAB9ASCN9A
SCHEMBL364340 0.88 RXRA (0.62) BCL2L1MCL1NR4A2NPC1RAB9A
SCHEMBL366812 0.86 MAOB (0.63) MAOBBCL2L1MCL1NR4A2SCN9A
SCHEMBL365173 0.86 MAOB (0.61) MAOBBCL2L1MCL1NR4A2NPC1
SCHEMBL10203178 0.86 SCN9A (0.66) MAOAMAOBBCL2L1MCL1SCN9A
SCHEMBL16240196 0.86 SCN9A (0.77) BCL2L1MCL1SCN9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A MAOA 3705/4885MAOB 3660/4885BCL2L1 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.